bioRxivBiophysicsPreprint
The G256E HCM mutation prolongs relaxation via altered nucleotide handling
Kerry Y. KaoiD, Matthew Carter ChildersiD, Divya PathakiD, Rama Reddy GoluguriiD, Timothy S. McMilleniD, Kathleen M. RuppeliD, James A. SpudichiD, Michael RegnieriD
Abstract
Mutations in myosin alter its motor functions in diverse ways by affecting different structural and chemo-mechanical events. Multidisciplinary strategies can be used to understand how varying alterations in motor function converge to common phenotypes like hypercontractility and hypertrophic cardiomyopathy (HCM). Here, we combined molecular dynamics (MD) simulations with protein biochemical and myofibril mechanical analyses to study the HCM-causing myosin variant G256E. MD simulations demonstrated that G256E induces structural changes that increase the work required to displace ADP.Mg2+ from actomysoin complex. Stopped-flow biochemical analysis demonstrated increased ADP affinity for actomyosin and single myofibril mechanics analysis demonstrated increased force generation and reduced ADP sensitivity of the early, slow phase of relaxation. Together, these results demonstrate that slower ADP release from myosin during contraction is a significant contributor to pathological contractile nature of the G256E mutation. This study highlights the importance of detailed chemo-mechanical analysis of mutations associated with hereditary cardiac diseases.
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: chromatin & epigenetic regulation
- research focus: protein folding & dynamics
- approach: experimental assay
- approach: biophysical modeling
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration
Soah Lee, Alison Schroer Vander Roest, … Daniel Bernstein·bioRxiv·Jun 8, 2023
- The hypertrophic cardiomyopathy mutation G768R makes cardiac myosin a high duty ratio motor
Divya Pathak, T Ozturk Dalpe, … Kathleen M. Ruppel·bioRxiv·Jun 6, 2026
- Mutations in the catalytic domain of human β-cardiac myosin that cause early onset hypertrophic cardiomyopathy significantly increase the fundamental parameters that determine ensemble force and velocity
Arjun S Adhikari, Kristina B Kooiker, … Kathleen M Ruppel·bioRxiv·Aug 9, 2016
- A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment
Robert C. Cail, Bipasha Barua, … E. Michael Ostap·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 24, 2025
- Myosin motor domains carrying mutations implicated in early or late onset Hypertrophic Cardiomyopathy have similar properties
C. D. Vera, C. A. Johnson, … L. A. LEINWAND·bioRxiv·Aug 10, 2019
- Single-molecule analysis sheds light on cardiac myosin dysfunction due to hypertrophic cardiomyopathy mutation A57D in ventricular myosin light chain-1 (MLC1v)
Tianbang Wang, Emrulla Spahiu, … Mamta Amrute‐Nayak·bioRxiv·Mar 9, 2026